Zebrafish is a bimonthly peer-reviewed journal focusing on research using zebrafish and other aquarium species including medaka, Fugu and Xiphophorus as models for studies of vertebrate development, toxicology and human disease. The Journal will serve as a forum for papers discussing research on comparative genomics and evolution, the genetic analysis of embryogenesis and disease and the cellular and molecular mechanisms of cell growth, differentiation and gene expression in these model species. The Journal will also publish papers describing novel methods, tools and experimental approaches using aquarium models.
Preparation of Manuscript
Please read all the instructions to authors before submitting.
Manuscripts should be organized with
(1) a title page containing the full title of the paper, the names and affiliations of all of the authors, as well as the mailing address, telephone number, fax number, and e-mail address of the corresponding author; (2) an Abstract of 200 words; (3) a concise, clearly worded and constructed Introduction; (4) Materials and Methods containing sufficient detail to allow for reproduction; (5) a Results section; (6) a Discussion involving interpretation of the results including their relationship to the existing body of knowledge in the field; (7) Acknowledgments ; and (8) References. Please follow the protocol described herein to avoid delay in publication. Authors should note that manuscripts may be edited if needed to ensure clear grammatical English usage.
To enhance the dissemination of generally useful technological advances and transgenic lines, Zebrafish introduced the new section TechnoFish, which highlights these innovations for the general zebrafish community. TechnoFish features two types of submissions:
Previews: Previews are designed to alert readers to important generally useful technical advances or valuable transgenic lines that they might otherwise miss, either because they are published as part of a larger research paper, or because they are published as a methods paper in a journal that zebrafish scientists would not typically view. Authors who feel that this is appropriate for their work will submit a short description (150 words or less), written in the third-person, which highlights why their method or transgenic line is of general interest. A figure should be included to draw interest, which is attractive in both black and white (for the printed version) and in color (for the online version). The submission will be rapidly reviewed to ensure that the technology is of general interest and is clearly described. There will be no publication charge for Previews. By submitting this, authors are also agreeing that all relevant plasmids, transgenic lines, etc., will be made available to all who request it. Please submit these directly to David Kimelman, PhD, University of Washington.
Methods: These papers are for brief descriptions of new methods, reagents, or transgenic lines that will be of widespread use in the zebrafish community. They are intended to be one printed page with one figure, with online supplemental information. These manuscripts will be peer-reviewed and submitted through the standard submission process.
Tables and Illustrations
Use Arabic numerals to number tables. Do not repeat information that is given in the text, and do not make a table for data that can be given in the text in one or two sentences. Provide titles for all tables. Define all acronyms in table footnotes. All other types of table footnotes should be designated using superscript letters, not symbols.
All illustrations should be numbered and labeled with the figure number. A legend should be supplied for each illustration, and all legends numbered consecutively and provided (double spaced) inin a separate file. Figures should be numbered in the order cited in the text.
Please follow these guidelines for submitting figures:
• Do NOT embed art files into a Word or PDF document.
• Line illustrations should be submitted at 1200 dpi.
• Halftones and color should be submitted at a minimum of 300 dpi.
• Save as either TIFF or EPS files.
• Color art must be saved as CYMK - not RGB.
• Black and White art must be submitted as grayscale – not RGB.
• Do NOT submit PowerPoint, PDF, Bitmap or Excel files.
Please name your artwork files with the submitting authors name i.e. SmithFig1.tif, SmithTable2.tif etc. Authors who do not follow these guidelines may have their submission returned to them without being reviewed.
You will be given directions on how to correct any files which do not pass.
ADDITIONAL INFORMATION ABOUT ART FILES
Converting Word or Excel files: Perhaps the best and easiest way to convert Word or Excel files into a format which is suitable for print is to scan them using the below guidelines:
- All files should be scanned at 100% size.
- 300 dpi
- Final color mode: cmyk
- savefile as: .tif or .eps
If you need directions on how to convert a Power Pointslide to acceptable format go to http://www.liebertpub.com/MEDIA/pdf/ppconvert.pdf
The Journal will publish color photographs, but the author must subsidize the cost of the color printing. For further details, contact the Publisher.
Author Disclosure Statement
In this portion of the paper, authors must disclose any commercial associations that might create a conflict of interest in connection with submitted manuscripts. This statement should include appropriate information for EACH author, thereby representing that competing financial interests of all authors have been appropriately disclosed according to the policy of the Journal. It is important that all conflicts of interest, whether they are actual or potential, be disclosed. This information will remain confidential while the paper is being reviewed and will not influence the editorial decision. Please see the Uniform Requirements for Manuscripts Submitted to Biomedical Journals at http://www.icmje.org/index.html#conflicts for further guidance. If no conflicts exist, the authors must state “No competing financial interests exist<br<
All references must be cited in the text using a superscript Arabic number. Arrange the reference list in numeric order as cited in the text. The first 6 authors must be listed; thereafter use "et al."
Parng C, Seng WL, Semino C, McGrath P. Zebrafish: A Preclinical Model for Drug Screening. Assay Drug Devel Technol 2002;1:41-48.
Nusslein-Volhard C: Zebrafish: A Practical Approach. Oxford University Press, Oxford, England, 2002.
Chapter in edited book:
Macdonald R: Zebrafish immunohistochemistry. In Molecular Methods in Developmental Biology: Xenopus and Zebrafish. Guille M and Guille M, (eds), pp. 77–88, Humana Press, Totowa, NJ, 1999.
When data from an unpublished source are given, supply the researcher's name. If work is in press, give the journal in which it is to be published or name of the publisher. Abbreviations of journal names should follow the style of Medline.
The author must obtain permission whenever it is required in conjunction with the reproduction of material such as figures and tables from copyrighted material. Written permission must be obtained from the publisher of the journal or book concerned. The publication from which the figure or table is taken must be listed in the reference list. Finally, a footnote of a reprinted table, or of the legend of a reprinted figure, should read, "reprinted by permission from [author name] et al." and list the appropriate reference. All permissions listings must be shown in manuscript; they cannot be entered on proofs.
Reprints may be ordered by following the special instructions that will accompany page proofs, and should be ordered at the time the corresponding author returns the corrected page proofs to the Publisher. Reprints ordered after an issue is printed will be charged at a substantially higher rate.
Zebrafish is published by Mary Ann Liebert, Inc., 140 Huguenot Street, New Rochelle, NY 10801-5215. Telephone: (914) 740–2100; fax: (914) 740–2101.
The views, opinions, findings, conclusions and recommendations set forth in any
Journal article are solely those of the authors of those articles and do not necessarily
reflect the views, policy or position of the Journal, its Publisher, its editorial
staff or any affiliated Societies and should not be attributed to any of them.